JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Methylation-based immune deconvolution in prostate cancer patients before and after radical prostatectomy

  • 0Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Cancer Causes & Control : Ccc +

|

October 10, 2024

|

October 10, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Radical prostatectomy did not significantly alter immune cell proportions six months post-surgery. This suggests that surgery-induced immune changes in prostate cancer patients may not be long-lasting.

Area Of Science

  • Immunology
  • Oncology
  • Genomics

Background

  • Surgery can temporarily suppress the immune system, potentially aiding cancer spread.
  • The long-term impact of prostate cancer surgery on immune function remains unclear.

Purpose Of The Study

  • To investigate long-term immune changes after radical prostatectomy for prostate cancer.
  • To compare immune cell subset dynamics in patients undergoing surgery versus active surveillance.

Main Methods

  • Serial blood samples were collected from prostate cancer patients pre- and post-radical prostatectomy (n=11) and from an active surveillance group (n=8).
  • Immune cell subsets were analyzed using genome-wide methylation data over a six-month period.

Main Results

  • No statistically significant changes in intra-individual immune cell proportions were observed six months after radical prostatectomy.
  • The active surveillance group also showed no significant intra-individual immune cell changes.
  • There were no differences in immune cell changes over time between the surgical and active surveillance groups.

Conclusions

  • Radical prostatectomy does not appear to cause meaningful long-term changes in circulating immune cell subsets.
  • Immune changes following prostate cancer surgery may be transient rather than persistent.

Keywords: